Patent · US Active

Carboxamide-pyrimidine derivatives as SHP2 antagonists

US11033547B2 · kind B2 · utility

0Cited by

2References

24Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Catherine Jorand-Lebrun · Arlington, US
Roch Boivin · North Chelmsford, US
Igor Mochalkin · Westford, US
Theresa L. Johnson · Salem, US
Nina Linde · Frankfurt am Main, DE
Doreen Musch · Darmstadt, DE
Deepak Kumar · Delhi, IN

Key dates

Filing date	Mar 9, 2020
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Mar 9, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to carboxamide-pyrimidine derivatives of the general formula I, or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.